Prothena Public Limited (PRTA) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access PRTA Annual Balance Sheets →
Balance sheet performance over multiple periods helps investors evaluate the financial resilience of Prothena Public Limited.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2026)
(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Assets
Cash & cash equivalent329.46
Cash & Short-term Investments329.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current9.74
Total Current Assets339.20
Equipment/Property/Plant Net1.96
Other Assets, Noncurrent8.73
Operating Lease Right Of Use Asset7.39
Restricted Cash Noncurrent0.86
Total Assets349.89
Liabilities
Accounts Payable, Current AC4.30
Other Liabilities, Current0.00
Deferred Revenue, Current DE1.63
Total Current Liabilities32.52
Total Long-term Debt0.00
Restructuring Reserve, Current RE8.59
Deferred Revenue, Noncurrent DE0.00
Other liabilities, Noncurrent22.76
Accrued Research And Development Current4.61
Total Liabilities37.28
Stockholders' Equity
Common Stock Value0.53
Additional Paid In Capital Common Stock1,625.80
Retained Earnings / Accumulated Deficit-1,313.71
Other Equity0.00
Common Stockholder's Equity312.62
Total Stockholder's Equity312.62
Liabilities & Stockholder's Equity349.89
4 historic quarters locked

Sign in to unlock the full Prothena Public Limited balance sheet history.

About Prothena Corp Public Ltd Co Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001559053-26-000022

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.